SCHEMBL4557425

SCHEMBL4557425

COC1CCc2cc(N3CCNS3(=O)=O)c(O)cc2C1

nearest known ligand 0.32

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
CYP2B6 P20813 1/20 0.32
DRD2 P14416 1/20 0.32
DRD1 P21728 1/20 0.32
MAPT P10636 2/20 0.31
NFKB1 P19838 1/20 0.31
THPO P40225 1/20 0.31
HIF1A Q16665 1/20 0.31
HSD17B10 Q99714 1/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
PIK3C3 Q8NEB9 1/20 0.31
KDM4E B2RXH2 1/20 0.31
PTPN1 P18031 1/20 0.31
PTPN2 P17706 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2931425 0.85 DRD2 (0.34) DRD2DRD1MAPTNFKB1THPO
SCHEMBL4738126 0.82 PTPN2 (0.34) DRD2DRD1MAPTNFKB1THPO
SCHEMBL627993 0.81 PTPN1 (0.51) PTPN1PTPN2
SCHEMBL4737027 0.71 CYP1A2 (0.31) CYP1A2CYP3A4CYP2C9CYP11B1CYP11B2
SCHEMBL4557489 0.70 PIK3C3 (0.31) PIK3C3PTPN1PTPN2
SCHEMBL629629 0.70 PTPN1 (0.46) PTPN1PTPN2
SCHEMBL629832 0.64 PTPN1 (0.46) PTPN1PTPN2
SCHEMBL630108 0.63 PTPN2 (0.48) PTPN1PTPN2
SCHEMBL629980 0.63 PTPN1 (0.46) PTPN1PTPN2
SCHEMBL22411831 0.62 PTPN2 (0.68) PTPN1PTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2089026-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE PROMOTION OF PHYSIOLOGICAL CARDIAC HYPERTROPHY Novartis AG (CH) 2009-08-19 EP disclosed
WO-2008070552-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE PROMOTION OF PHYSIOLOGICAL CARDIAC HYPERTROPHY NOVARTIS AG (CH) 2008-06-12 WO disclosed